BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17606371)

  • 41. Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors.
    Zhao Z; Pissarnitski DA; Josien HB; Bara TA; Clader JW; Li H; McBriar MD; Rajagopalan M; Xu R; Terracina G; Hyde L; Song L; Zhang L; Parker EM; Osterman R; Buevich AV
    Eur J Med Chem; 2016 Nov; 124():36-48. PubMed ID: 27560281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small molecule microarray-facilitated screening of affinity-based probes (AfBPs) for gamma-secretase.
    Shi H; Liu K; Xu A; Yao SQ
    Chem Commun (Camb); 2009 Sep; (33):5030-2. PubMed ID: 19668839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of pharmacophore model, synthesis and biological evaluation of N-phenyl-1-arylamide and N-phenylbenzenesulfonamide derivatives as BACE 1 inhibitors.
    Huang W; Yu H; Sheng R; Li J; Hu Y
    Bioorg Med Chem; 2008 Dec; 16(24):10190-7. PubMed ID: 19013073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides.
    Bertini S; Ghilardi E; Asso V; Granchi C; Minutolo F; Pineschi M; Di Bussolo V; Bortolato A; Moro S; Saba A; Macchia M
    Bioorg Med Chem; 2010 Nov; 18(22):7991-6. PubMed ID: 20934348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrocyclic inhibitors of beta-secretase: functional activity in an animal model.
    Stachel SJ; Coburn CA; Sankaranarayanan S; Price EA; Wu G; Crouthamel M; Pietrak BL; Huang Q; Lineberger J; Espeseth AS; Jin L; Ellis J; Holloway MK; Munshi S; Allison T; Hazuda D; Simon AJ; Graham SL; Vacca JP
    J Med Chem; 2006 Oct; 49(21):6147-50. PubMed ID: 17034118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel orally active, dibenzazepinone-based gamma-secretase inhibitors.
    Peters JU; Galley G; Jacobsen H; Czech C; David-Pierson P; Kitas EA; Ozmen L
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5918-23. PubMed ID: 17869099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and synthesis of tricyclic sulfones as gamma-secretase inhibitors with greatly reduced Notch toxicity.
    Xu R; Cole D; Asberom T; Bara T; Bennett C; Burnett DA; Clader J; Domalski M; Greenlee W; Hyde L; Josien H; Li H; McBriar M; McKittrick B; McPhail AT; Pissarnitski D; Qiang L; Rajagopalan M; Sasikumar T; Su J; Tang H; Wu WL; Zhang L; Zhao Z
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2591-6. PubMed ID: 20236824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aminothiazoles as γ-secretase modulators.
    Lübbers T; Flohr A; Jolidon S; David-Pierson P; Jacobsen H; Ozmen L; Baumann K
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6554-8. PubMed ID: 21924610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thiazole-diamides as potent gamma-secretase inhibitors.
    Chen YL; Cherry K; Corman ML; Ebbinghaus CF; Gamlath CB; Liston D; Martin BA; Oborski CE; Sahagan BG
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5518-22. PubMed ID: 17764937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three-dimensional quantitative structure-activity relationship modeling of gamma-secretase inhibitors using molecular field analysis.
    Sammi T; Silakari O; Ravikumar M
    Chem Biol Drug Des; 2008 Feb; 71(2):155-66. PubMed ID: 18221306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA damage-inducing agents elicit gamma-secretase activation mediated by oxidative stress.
    Jin SM; Cho HJ; Jung ES; Shim MY; Mook-Jung I
    Cell Death Differ; 2008 Sep; 15(9):1375-84. PubMed ID: 18421302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-Bridged bicyclic sulfonamides as inhibitors of gamma-secretase.
    Bowers S; Probst GD; Truong AP; Hom RK; Konradi AW; Sham HL; Garofalo AW; Wong K; Goldbach E; Quinn KP; Sauer JM; Wallace W; Nguyen L; Hemphill SS; Bova MP; Basi GS
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6952-6. PubMed ID: 19879755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo.
    Machauer R; Laumen K; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Jaton AL; Desrayaud S; Staufenbiel M; Rabe S; Paganetti P; Neumann U
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1366-70. PubMed ID: 19195887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice.
    Philipson O; Lannfelt L; Nilsson LN
    FEBS Lett; 2009 Sep; 583(18):3021-6. PubMed ID: 19683527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
    Kreft AF; Martone R; Porte A
    J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467
    [No Abstract]   [Full Text] [Related]  

  • 56. Novel orally active morpholine N-arylsulfonamides gamma-secretase inhibitors with low CYP 3A4 liability.
    Josien H; Bara T; Rajagopalan M; Clader JW; Greenlee WJ; Favreau L; Hyde LA; Nomeir AA; Parker EM; Song L; Zhang L; Zhang Q
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6032-7. PubMed ID: 19800786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of gamma-secretase activity by helical beta-peptide foldamers.
    Imamura Y; Watanabe N; Umezawa N; Iwatsubo T; Kato N; Tomita T; Higuchi T
    J Am Chem Soc; 2009 Jun; 131(21):7353-9. PubMed ID: 19432477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting.
    Rajendran L; Schneider A; Schlechtingen G; Weidlich S; Ries J; Braxmeier T; Schwille P; Schulz JB; Schroeder C; Simons M; Jennings G; Knölker HJ; Simons K
    Science; 2008 Apr; 320(5875):520-3. PubMed ID: 18436784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
    Camps P; Formosa X; Galdeano C; Muñoz-Torrero D; Ramírez L; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Huertas O; Dafni T; Luque FJ
    J Med Chem; 2009 Sep; 52(17):5365-79. PubMed ID: 19663388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.
    Barrow JC; Stauffer SR; Rittle KE; Ngo PL; Yang Z; Selnick HG; Graham SL; Munshi S; McGaughey GB; Holloway MK; Simon AJ; Price EA; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Espeseth AS; Xu M; Huang Q; Wolfe A; Pietrak B; Zuck P; Levorse DA; Hazuda D; Vacca JP
    J Med Chem; 2008 Oct; 51(20):6259-62. PubMed ID: 18811140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.